Ticagrelor showed greater antiplatelet efficacy than clopidogrel in diabetic patients post-PCI

Ticagrelor showed greater antiplatelet efficacy than clopidogrel in diabetic patients post-PCI

2020.09.07

Clopidogrel is currently the only P2Y12 inhibitor with class I recommendation in patients after percutaneous coronary intervention (PCI) for chronic coronary syndromes (CCS). However, it is noted...


Mid-range ejection fraction in STEMI patients linked to higher adverse outcomes

Mid-range ejection fraction in STEMI patients linked to higher adverse outcomes

2020.08.31

Evidence is sparse on the impact of mid-range ejection fraction (mrEF) on clinical outcomes including ventricular arrhythmias and in ST-segment-elevation myocardial infarction (STEMI). Therefore, a...


Effects of the Beijing tobacco control policy on AMI and stroke hospital admissions

Effects of the Beijing tobacco control policy on AMI and stroke hospital admissions

2020.08.24

The MPOWER tobacco control policy package has been implemented in Beijing since June 2015. In an interrupted time series study, researchers sought to assess the impact of the policy on hospital...


Abnormal glucose tolerance linked to increased MACE risk among patients with MI

Abnormal glucose tolerance linked to increased MACE risk among patients with MI

2020.08.17

Patients with acute myocardial infarction (MI) have a high prevalence of newly discovered abnormal glucose tolerance (AGT), according to results from a meta-analysis. Data were extracted from...


Impact of ticagrelor on coronary artery function in East Asians

Impact of ticagrelor on coronary artery function in East Asians

2020.08.10

In a study, researchers hypothesized that ticagrelor might improve coronary microvascular function, and investigated the antiplatelet effect of low-dose ticagrelor in East Asian patients.A total of...


Ticagrelor more efficacious than clopidogrel in ACS patients undergoing PCI: results from a meta-analysis

Ticagrelor more efficacious than clopidogrel in ACS patients undergoing PCI: results from a meta-analysis

2020.08.03

The Platelet Inhibition and Patient Outcomes (PLATO) study reported that ticagrelor plus aspirin (TA) was more effective than clopidogrel plus aspirin (CA) without increasing the risk of major...


Obstructive coronary artery disease vs non-obstructive coronary arteries on angiography in ACS patients

Obstructive coronary artery disease vs non-obstructive coronary arteries on angiography in ACS patients

2020.07.27

With the growing interest in patients with myocardial infarction with non-obstructive coronary arteries, there is a need to define an even broader group of patients with the syndrome of myocardial...


Cardiac abnormalities found in half of all COVID-19 patients

Cardiac abnormalities found in half of all COVID-19 patients

2020.07.20

In a global survey, cardiac abnormalities were observed in half of all COVID-19 patients undergoing echocardiography. Abnormalities were often unheralded or severe, and imaging changed management in...


Relationship between geriatric conditions, choice of therapy and clinical outcomes in elderly ACS patients

Relationship between geriatric conditions, choice of therapy and clinical outcomes in elderly ACS patients

2020.07.13

The clinical benefit of invasive therapy in elderly patients with acute coronary syndrome (ACS) remains unclear, and the decision-making process to treat this growing patient group is also debatable...


Antithrombotic management patterns in ACS Chinese patients

Antithrombotic management patterns in ACS Chinese patients

2020.07.06

An observational study revealed that most Chinese patients received at least one antiplatelet (AP) medication for up to 5 years after an acute coronary syndrome (ACS) event.This multicentre,...